Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis.
Circulating microRNA-21 (miR-21) is known to be aberrantly expressed in hepatocellular carcinoma (HCC) patients, and this implies that microRNA-21 is a promising and novel indicator of HCC. However, a systematic evaluation of the performance of microRNA-21 as a diagnostic marker for HCC has yet to b...
Main Authors: | Qibin Liao, Peiyu Han, Yue Huang, Zhitong Wu, Qing Chen, Shanshan Li, Jufeng Ye, Xianbo Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4483261?pdf=render |
Similar Items
-
Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
by: Filippo Pelizzaro, et al.
Published: (2021-07-01) -
Importance of circulating microRNA-122 for hepatocellular carcinoma
by: Engin Onan, et al.
Published: (2021-09-01) -
Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma
by: Xiaochang Wu, et al.
Published: (2022-10-01) -
MicroRNA Biosensors for Early Detection of Hepatocellular Carcinoma
by: Xiaogang Lin, et al.
Published: (2023-09-01) -
Development of MicroRNA Therapeutics for Hepatocellular Carcinoma
by: Rajagopal N. Aravalli
Published: (2013-03-01)